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Background: Astronauts conducting extravehicular activities undergo
detompression to a lower ambient pressure, potentially resulting in gas
bubble formation within the tissues and venous circulation. Additionally,
exposure to mi( rogravity produces fluid shifts within the body leading
to cardiovascular deconditioning. A lower incidence of decompression
illness in actual spaceflight compared with that in ground-based altitude
chamber flights suggests that there is a possible interaction between
microgravity exposure and decompression illness. Hypothesis: The pur-
pose of this study was to evaluate the cardiovascular and pulmonary
effects of simulated hypobaric decompression stress using a tail suspen-
sion (head-down tilt) model of microgravity to produce the fluid shifts
associated with weightlessness in conscious, chronically instrumented
rats. Methods: Venous bubble formation resulting from altitude decom-
pression illness was simulated by a 3-h intravenous air infusion. Cardio-
vascular de(onditioning was simulated by 96 h of head-down tilt. Heart
rate, mean arterial blood pressure, central venous pressure, left ventricu-
lar wall thickening and ( ardiac output were continuously recorded. Lung
studies were performed to evaluate ederna formation and (ompliance
measurement. Blood and pleural fluid were examined for changes in
white cell counts and protein concentration. Results: Our data demon-
strated that in tail-suspended rats subjected to venous air infusions, there
was a reduction in pulmonary edema formation and less of a decrease
in cardiac output than o(curred following venous air infusion alone.
Mean arterial blood pressure and myocardial wall thickening fractions
were unchanged with either tail-suspension or venous air infusion. Heart
rate decreased in both conditions while systemic vascular resistance
increased. Conclusions: These differences may be due in part to a
change or redistribution of pulmonary blood flow or to a diminished
cellular response to the microvascular insult of the venous air emboliza-
tion.
PERATIONALLY IMPORTANT medical challenges
of manned spaceflight include microgravity-in-
duced cardiovascular deconditioning, total body calcium
loss, and the risk of decompression illness (DCI) during
extravehicular activity (EVA). Altitude DCI deserves
particular attention because it is a preventable complica-
tion, but one that can have serious consequences if left
unattended (26). Evaluation of the interaction between
microgravity exposure and decompression illness is ap-
propriate in view of plans for extended duration mis-
sions and an overall increase in the number of EVA's
required for construction of the Space Station. It is in-
tended that such investigation will lead to a better under-
standing of the interplay between DCI and the human
cardiovascular system in a microgravity environment.
Decompression illness results from the formation and
growth of gas bubbles within the tissues and venous
blood; e.g., venous air emboli (VAE). Associated symp-
toms can range from mild skin itching or simple joint
pain to central nervous system involvement and even
cardiovascular collapse. The pathophysiology of DCI
may also affect the lungs as the venous bubbles obstruct
the pulmonary microcirculation (8,10) decreasing cardiac
output (CO), increasing pulmonary vascular pressures
and altering lung fluid balance. The preponderance of
actual symptoms, however, involve limb pain that is pre-
sumably caused by extravascular bubbles.
The adaptation of the cardiovascular system to the mi-
crogravity environment (cardiovascular deconditioning)
appears to be due in part to a cephalad fluid shift, and has
been extensively studied in the conscious rat (22). Astro-
naut EVA's have brought into question the potential rela-
tionship between cardiovascular deconditioning and hypo-
baric DCI. Compared with careful ground-based studies
conducted in hypobaric chambers, there is a lower inci-
dence of DCI in space during the astronaut EVA's than
would be predicted (25). These studies have established
the predicted incidence of DCI expected, both in relation
to the final altitude following a direct or staged decompres-
sion, and subsequent to washout of tissue inert gas (e.g.,
nitrogen) by oxygen prebreathing prior to decompression
(14). In addition, other factors such as exercise, ambulation,
time at altitude and individual susceptibility have been
examined (1). The interaction between hypobaric decom-
pression and the deconditioned cardiovascular system has
not been previously evaluated. The purpose of this study
was to assess pulmonary and hemodynamic effects of sim-
ulated microgravity and hypobaric decompression illness
in the conscious rat.
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METHODS
All experimentsandprocedureswereapprovedbythe
InstitutionalAnimalCareand UseCommitteeat The
Universityof TexasMedicalSchoolat Houston.Six
groupsof ratswerestudied.Groups1and2wereused
to assessthe hemodynamiceffectsof tail-suspension
withandwithoutvenousair infusion,whereasgroups
3-6 wereusedfor biochemicalnalysis.Eachanimal
servedasitsowncontrol.
Cardiovascular Function (Groups 1-2)
Instrumentation: The rats were anesthetized with halo-
thane, intubated and ventilated under isothermic condi-
tions. A left parasternal thoracotomy was performed and
the pericardium exposed and sectioned. A 20-MHz
pulsed Doppler flow probe was then placed around the
ascending aorta for cardiac output measurement. The
displacement probe used to measure left ventricular wall
thickening was sutured to the left ventricular wall and
an 18-gauge thoracic drain was positioned until closure
of the thorax.
The ultrasonic flow probe leads were tunneled to the
dorsum of the neck for externalization and the surgical
wounds closed. Polyvinyl catheters were placed into the
abdominal aorta via the femoral artery and the jugular
vein for measurement of arterial blood pressure and cen-
tral venous pressure. The catheters were also tunneled
to the neck dorsum. The lungs were reinflated under
vacuum and the wounds were infiltrated with bupiva-
caine (0.5%) for post-operative analgesia. Antibiotic ther-
apy (gentamycin 5 mg" kg *IM) was initiated for a mini-
mum of 5 ds. The animals were weighed daily and in-
spected for signs of infection.
The single-crystal pulsed Doppler technique for mea-
surement of changes in myocardial wall thickening frac-
tion has previously been described in detail (16). The
displacement modules operated at a pulse repetition fre-
quency of 8 KHz and an ultrasonic frequency of 20 MHz.
The pulsed Doppler system measured displacement of
myocardial tissue through a sample volume with the use
of a single crystal that alternately serves as transmitter
and receiver. Briefly, it operates by integrating the veloc-
ity of the various myocardial layers that pass back and
forth through a range-gated sample volume located
within the myocardium at a fixed distance from the epi-
cardial surface where the crystal is attached to the myo-
cardial wall. Thickening fraction is defined as the maxi-
mum excursion recorded during systole, divided by the
sample volume depth. The range was set at a 2-3 mm
depth near the endocardium.
The pulsed Doppler system for measurement of car-
diac output in small animals has also been described
in detail (17). Briefly, a linear relationship between true
volume flow and Doppler frequency shift has previously
been demonstrated in a variety of blood vessels with
diameters ranging from 1-11 mm. At a pulse repetition
frequency (PRF) of 125 KHz, the Doppler system re-
solves frequency shifts of up to 62.5 KHz (PRF/R) at a
maximum range (R) from 0.6-6 mm and a spatial range
of 0.3 mm. True blood flow was calculated from the max-
imum Doppler frequency shift using the standard rela-
tionship described by lshida et al. (18). The Doppler flow
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probes were manufactured according to previously de-
scribed techniques (16,17).
Hemodynamic measurements: All hemodynamic vari-
ables [e.g., heart rate (HR), mean arterial (MAP) and cen-
tral venous pressure (CVP), left ventricular wall thick-
ening (WT), and cardiac output (CO)] were processed
with the multichannel pulsed Doppler flow/dimension
system and were continuously displayed on a Gould
physiograph. The wall thickening fraction (TF%) was cal-
culated as 100 × SE/R (SE, the systolic excursion and R,
the range-gate depth). Systemic vascular resistance (SVR)
was calculated as MAP/CO.
Experimental protocols: Group 1, (n = 8) designated
VAE, was exposed to 3 h of venous air infusion. We
elected to use VAE given as a continuous infusion to
simulate the prolonged bubbling that is reported with
hypobaric decompression exposures used to simulate an
astronaut EVA. In these cases, VAE are detected with
Doppler ultrasound probes for periods lasting several
hours during the period of decompression. Injecting ve-
nous gas very slowly in the rat simulated that particular
feature of decompression effects. Although this tech-
nique is well established for a number of species (8),
little data are available for the rat. After hemodynamic
parameters stabilized, rats received the venous air infu-
sions into the central venous catheter at a rate of 0.015
ml-kg *.min * for 180 rain. Cardiovascular data were
recorded at 15, 30, 45, 60, 120 and 180 rain during venous
air infusion and at 15, 30, 45, 60, and 120 min and 24 h
post infusion.
Group 2 (n = 8), designated TS-VAE, experienced car-
diovascular deconditioning by tail-suspension with a 30 °
head-down tilt. The tail suspension model has previously
been described in detail (21) and is widely used by inves-
tigators to simulate the fluid shifts commonly observed
upon exposure to microgravity. Briefly, rats were fitted
with a flexible foam-tape cast applied to the proximal
half of the tail. The cast was attached to a swivel and
the rats were suspended in a 30 ° head-down tilt. This
apparatus allowed the rats to rotate in a 360 ° arc using
their forelimbs, and permitted free access to food and
water in a light/dark cycled environment. Following 96
h tail-suspension, and while maintained in the sus-
pended position, the animals were infused with venous
air for 3 h as described above.
Puhnona_ Measurements (Groups 3-6)
Group 3 consisted of norrnoactive controls; group 4,
tail-suspension only; group 5, VAE only; and group 6,
tail-suspension-VAE. The rats in groups 5 and 6 received
venous air infusions, as described above. Immediately
post infusion, the animals were anesthetized with pento-
barbital sodium (50 mg IP). An arterial blood sample was
collected anaerobically for blood gas and plasma protein
analysis. The animals were euthanized by exsanguina-
tion and the lungs were removed for the following mea-
surements.
Pulmonary edema measurement: The amount of blood-
free extravascular fluid (edema) formation was mea-
sured using a modified method of Pearce (23) to account
for the residual blood volume in the organ. The extravas-
cular lung water (EVLW) was expressed as the extravas-
cular fluid to dry weight ratio.
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Fig. 1. Systemic vascular resistance (SVR) and cardiac output (CO)
are plotted as percent change from baseline over time for the TS-VAE
and VAE groups. Venous air infusion started at Time = 0 and continued
until Time = 3 h TS-VAE SVR values were significantly elevated from
the onset of tail-suspension and throughout the air infusion. SVR was
also elevated in the VAE group during the air infusion and for 2 h
recovery. Cardiac output was decreased significantly from baseline dur-
ing the air infusion in both groups, and significantly different from each
other at 180 min infusion.
Lung compliance: For quasi-static lung compliance mea-
surement, the lungs were isolated, degassed under vac-
uum (29), placed in a heated humidified chamber and
connected via a tracheal catheter to an infusion/with-
drawal pump and an airway pressure transducer. The
lungs were inflated to 30 cm H20 at a rate of 20
ml. min 1, and equilibrated for 15 min while maintaining
30 cm H20 pressure. Inflation/deflation pressure-vol-
ume curves were then collected. The compliance mea-
surements were taken from the deflation limb of the
curve between 30% and 70% of total lung capacity.
Bronchoalveolar lavage (BAL): The trachea was cannu-
lated and the airways were lavaged with 10 ml cold nor-
mal saline (5°C). This procedure was repeated 6 times
for a total lavage volume of 60 ml. The BAL samples
were pooled. Total BAL protein was assayed using the
Lowry method with modification for the presence of
lipid from the 60 ml pooled lavage (19). BAL hemoglobin
levels were measured using a modified benzidine assay.
Cell counts: Total white cell counts were performed
on BAL, pulmonary and arterial blood and pleural fluid
using a Neubauer hemocytometer with EDTA stabiliza-
tion. Differential cell counts were performed with micro-
scopic survey using Wright-Geimsa stain.
Data Analysis
Data were analyzed using ANOVA with Dunnett's
correction for the individual comparisons in the bio-
chemistry studies. The cardiovascular data were ana-
lyzed using a 2-way ANOVA. Individual comparisons
were analyzed using Student's t-test with Bonferroni cor-
rection. Significance was considered at p < 0.05.
RESULTS
Cardiovascular measurements: In the TS-VAE group,
SVR increased significantly by 28% from the onset of
tail-suspension and remained elevated throughout the
venous air infusion (Fig. 1). In the VAE group, SVR in-
creased significantly by 23% above baseline within 60
min of venous air infusion and remained elevated for 5
h. SVR in the VAE group returned to baseline within 6
h. CVP remained unchanged in both groups.
Cardiac output in the VAE group decreased by 26%
by the end of the 180 min venous air infusion (Fig. 1).
This was significantly greater than the TS-VAE group,
whose CO decreased by 9%. In the TS-VAE group, how-
ever, tail suspension alone caused a 11% decrease (non-
significant) in CO prior to the venous air infusion. De-
creases in CO from baseline were significant at 1, 2 and
3 h of venous air infusion for both TS-VAE and VAE
groups, versus control. CO returned to baseline within
24 h after venous air infusion. Arterial blood pressure
was not significantly altered by either the tail-suspension
or VAE. WT remained unchanged in response to tail-
suspension or venous air infusion.
TS-VAE and VAE rats showed a similar response in
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Fig. 2. Heart rate (HR) and mean arterial pressure (MAP) are plotted
as a function of time. Venous air infusion started at Time - O and
continued until Time = 3 h. MAP values were not significantly changed.
HR decreased significantly in both groups during the air infusion.
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TABLE 1. LUNG EDEMA, COMPLIANCE AND BLOOD (;AS DATA.
Control TS VAE TS-VAE
EVLW 4.18 _+ 0.21 3.811 _+ 0.41 6.02 +_ 11.68"§ 4.78 _+ 0.73*
Compliance 2.21/ + 0.22 2.10 _+ 0.21 2.00 _+ 11.118 1,90 _+ 017
Paoe (mmHg) 89.90 + 5.18 91.00 _+ 8.83 77.20 + 7.78 75.70 ,+ 16,86
Pa¢'o, (mmHg) 44.90 + 2.35 50.30 + 3.75 47.20 + 2.33 47.50 + 5.8{}
pH 7.35 + (}.1/2 7.25 + 0.02 7.24 + (}.(}4 7.27 ,+ 0.03
Data are represented as mean _+ S.D.
* p < (}.05 compared with control.
§ p < 0.05 compared with TS-VAE
EVLW = extravascular lung water ratio.
heart rate to venous air infusion. HR decreased signifi-
cantly by the first hour of air infusion and remained
decreased until the end of the infusion. The differences
between the two groups were not significant. In both
groups, HR returned to baseline within 24 h (Fig. 2).
Pulmonary measurements: In the VAE group, lung wet-
to-dry ratio was increased significantly as compared to
the three other groups. TS-VAE rats also showed a sig-
nificant increase in lung wet-to-dry ratio as compared to
the control group. Tail suspension alone did not cause a
significant increase in extravascular lung water. Arterial
blood gas values, pH, Paco2 and Pao2 were not different
from control value in any experimental group, although
the decrease in Pao2 and the increase in Paco2 seen in
the VAE and TS-VAE groups were consistent with the
pathologic pulmonary changes reported with DCI. Pul-
monary compliance was unchanged in all experimental
groups (Table I).
Total arterial white blood cell counts (WBC) were un-
changed in all experimental groups (Table II, top). Pul-
monary arterial blood white cell counts were signifi-
cantly increased, however, in the VAE group versus con-
trols, but neither the TS or the TS-VAE groups showed
significant differences from the control group. Pleural
fluid white blood cell count was decreased in the VAE
group versus the controls. This appeared to be a dilu-
tional effect due to an increase in pleural fluid volume.
BAL WBC counts were unchanged. Arterial blood neu-
trophil counts in both the TS-VAE and the VAE groups
were significantly increased over control. Pulmonary and
systemic arterial neutrophil counts were significantly in-
creased in both the VAE and the TS-VAE groups versus
the control group (Table II). Pleural fluid neutrophil
counts were increased significantly in all experimental
groups versus the control.
Pleural fluid protein concentration was increased in
the VAE group versus the controls, but there was no
significant change in either the TS or the TS-VAE groups.
Plasma protein levels were unchanged (Table I|, bottom).
BAL protein was unchanged in both TS-VAE and in VAE
rats (Table II).
DISCUSSION
Previous reports describing cardiopulmonary re-
sponses to significant decompression illness included hy-
potension, pulmonary hypertension, pulmonary edema,
decreased lung compliance, hemoconcentration and hyp-
oxemia 13,7,10,12,15). In similar conditions, Bove et al.
observed increased systemic vascular resistance, tachy-
cardia, increased central venous pressure and decreased
cardiac output (3). Cardiovascular symptom expression
and severity depend primarily on the extent of the de-
compression injury, and hence the degree of venous bub-
ble formation. In our experimental design, the use of a
venous air dose standardized by weight insured that the
venous gas insult was uniform throughout the study
population. Our findings demonstrate an attenuation in
the response to both pulmonary edema formation and
the decrease in cardiac output with simulated weight-
lessness and venous embolization (TS-VAE group).
TABLE 11. CELL COUNTS AND PROTEIN DATA.
Control TS VAE TS-VAE
Total WBC (cells- mm _)
Arterial
Pulmonary
BAL
Pleural
Neutrophils (percentage of total WBC)
Arterial
Pulmonary
BAL
Pleural
Protein (mg'dl _}
Plasma
BAL
Pleural
7920 _+ 386 7831 + 838 7975 _+ 1448 6{}66 +_ 1051
7970 +_ 427 8903 + 1074 13139 +_ 1242" 10457 _+ 1840
674 + 53 371 _+ 61 638 + 141 880 ,+ 185
54462 _+ 5050 60133 .+ 91119 20539 .+ 3005* 4616'3 + 111354
14.911 ,+ 1.34 29.60 + 6.34 70.10 +- 2.99* 68.10 +_ 6.28*
11.27 + 1/.96 24.10 _+5.17 55.10 _+4.38* 52.95 _+ 31"
0.68 + 0.19 2.60 ,+ 1.66 3.20 _+ 1.52 2.30 _+ 0.75
1.63 +- 0.24 4.60 _+ 0.54* 11.40 + 0.32* 10.60 ,+ 1.09"
48.30 + 2.09 51.92 _+ 1.66 50.45 + 2.33 49.1"3 +_ 2.85
7.08 _+ 0.60 8.55 -+ 0.50 2{}.06 _+ 4.92 14.91 _+ 8.72
18.64 ,+ 1.14 16.25 _+ 1.27 27.68 + {}.97* 13.77 ,+ 2.81
WBC = white blood cells.
Data are represented as mean ,+ SD.
* p < 0.05 compared with control.
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Several mechanisms may be involved in the response
of the deconditioned cardiopulmonary system to venous
air embolization. The changes in cardiac output may be
due either to fluid shifts or to a direct effect on myocar-
dial function. The effects on the lungs include vascular
distension, changes in volume, changes in ventilation to
perfusion matching and potential changes in diffusing
capacity (28). Additional factors may include mediator-
induced changes in vascular tone and endothelial perme-
ability (27), lymphatic recruitment (30), as well as hyp-
oxic pulmonary vasoconstriction.
In the present study, there was a slight but non-sig-
nificant decrease in cardiac output with tail suspension,
a finding that in magnitude is consistent with other stud-
ies (4). This change could be expected to prolong recov-
ery from a venous gas insult, possibly by decreasing pul-
monary blood flow and thereby reducing the rate of gas
embolus washout. However, venous air infusion pro-
duced an acute decrease in cardiac output in all animals,
whereas in the TS-VAE group, the decrease in cardiac
output was significantly less than the decrease experi-
enced by the VAE alone group. It might therefore be
inferred that even though both groups demonstrated ap-
proximately the same total decrease in cardiac output,
the initial decrease experienced by the TS-VAE group
occurred prior to the VAE and therefore may have al-
lowed for compensatory changes to occur.
The result of a higher cardiac output in the TS-VAE
group (after first hour of air infusion) relative to the VAE
group may have allowed an increase in pulmonary per-
fusion enabling deeper penetration of the emboli into the
pulmonary vascular tree. The emboli would thus block
a smaller segment of the pulmonary vasculature and
therefore obstruct less of the pulmonary blood flow. This
could result in a lower pulmonary artery pressure and
less edema formation. A higher cardiac output might
also increase the diffusion of gas from the emboli into the
surrounding blood by exposing the emboli to a greater
volume of blood per unit time, resulting in a more rapid
rate of resolution (20). This process might also be influ-
enced by accumulation of protein and coagulation prod-
ucts at the blood-bubble interface (24). Measurement of
left ventricular myocardial wall thickening fraction, an
indicator of myocardial contractility, demonstrated no
direct effects of either tail suspension or venous air em-
boli on the myocardium.
We observed that the systemic vascular resistance was
increased initially in the TS-VAE group, in response to
tail-suspension, with no further increase during venous
air embolization. An analogous response in the pulmo-
nary circulation, especially when venous bubbles ob-
struct pulmonary vessels, could result in a smaller in-
crease in pulmonary artery pressure with venous air em-
bolization than would be expected, leading to a decrease
in pulmonary edema formation. Direct evidence for such
a mechanism is unavailable.
The decrease (nonsignificant) in HR with the VAE in
both groups was consistent with other reports of VAE or
decompression in dogs (6,7). Possible mechanisms may
include a bundle branch block if the insult was sufficient
to cause myocardial ischemia (13) or a reflex-mediated
response where the right heart chamber volumes are
overwhelmed due to the venous gas challenges (5). Both
ET AL.
of these mechanisms are usually reported with large
VAE doses, however, that are sufficient to cause systemic
hypotension.
Simulated microgravity has been shown to improve
ventilation to perfusion ratio via central fluid shifts (14).
This might improve tolerance to pulmonary air emboli
both by maximally recruiting the pulmonary vasculature
and by optimizing the lung's ability to exchange gas,
thereby eliminating the gas via the alveoli. This too could
result in a decrease in pulmonary edema formation, as
seen in our studies.
Indirect effects of venous air bubbles include neutro-
phil activation and mediator release (9,27) resulting in
modification of vascular permeability and tone with con-
sequent pulmonary edema formation. Evidence of this
process was observed in all animals exposed to venous
air infusion. Arterial, pleural and pulmonary arterial
neutrophil percentages were increased in both the TS-
VAE and the VAE groups, but only the VAE group
showed significant changes in systemic arterial and pleu-
ral total white blood cell count, suggesting a possible
mechanism for increased mediator activation in the VAE
group as compared to the TS-VAE group. The decreased
BAL and pleural protein values further suggest that the
permeability of the microvascular and alveolar mem-
branes were less affected in the tail-suspension VAE rats
than the VAE alone.
Conclusions drawn from the present study are subject
to certain limitations. It has been shown by other investi-
gators that venous gas emboli will be distributed ac-
cording to the gravity vector. However, Chang et al. re-
ported that the size of the bubble, the speed of the blood
flow and the size of the vessels do play a role. The au-
thors found that, under most circumstances, the emboli
followed the higher branch of a bifurcation (11). While
the current model mimics the greater homogeneity in
blood flow seen in microgravity, one would still expect
a preponderance of emboli in the "upper" lobes. Addi-
tionally, the bubbles produced by venous air emboliza-
tion are larger than DCI-induced bubbles, consequently
some differences in pulmonary arterial occlusion pat-
terns and possibly in surface-area dependent processes
such as cellular activation and lung fluid balance might
be expected. Although the results of the present study
reflect some cardiopulmonary changes, clinical symp-
toms of DCI involving limb pain are usually attributed
to extravascular gas.
Several theories have been reported to explain the ob-
served low incidence of hypobaric decompression illness
during EVA. A decrease in the formation of micronuclei
due to reduced stress on the muscles, tendons and liga-
ments of the joints as a consequence of reduced activity
(exposure) in the microgravity environment has been de-
scribed (25). Additional reasons may involve actual re-
porting discrepancies related to operational factors such
as crew motivation, redirected attention, masking of sub-
tle pain, misinterpreting actual symptoms or actual re-
luctance to report DCI (2). The results of the present
study do suggest, however, that more than one process
may be responsible for the decreased incidence of DCI
(at least in terms of cardiopulmonary effects), including
an overall increase in tolerance to the combined effects
of simulated microgravity and decompression.
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